Federal Register #DEA-1694

DEA Notice: Bulk Manufacturer Registration Application for Controlled Substances by Royal Emerald Pharmaceuticals

This notice from the Drug Enforcement Administration (DEA) announces an application by Royal Emerald Pharmaceuticals to become a bulk manufacturer of Schedule I controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEM/Vendor: - Royal Emerald Pharmaceuticals (applicant and manufacturer) - Products/Services Requested: - Bulk manufacturing registration for: - Marihuana Extract (drug code 7350) - Marihuana (drug code 7360) - Tetrahydrocannabinols (drug code 7370) - No specific quantities provided - Purpose: To supply botanical raw material and/or active pharmaceutical ingredients (API) to DEA-registered researchers and manufacturers - Unique/Notable Requirements: - Registration is strictly for manufacturing and supplying to DEA-registered entities - No other activities for these substances are authorized under this registration - DEA is soliciting comments and objections from other registered bulk manufacturers and applicants - Place of Performance/Delivery: - DEA is the contracting office; no specific manufacturing location provided

Description

Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic classes of controlled substances, including Marihuana Extract, Marihuana, and Tetrahydrocannabinols, all Schedule I substances. The company plans to bulk manufacture these substances to provide botanical raw material and/or active pharmaceutical ingredients to DEA-registered researchers and manufacturers. Comments and objections to the application can be submitted electronically or in writing before June 1, 2026. This notice is issued by the Drug Enforcement Administration under the Department of Justice.

View original listing